logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

NSCLC: ganetespib disappoints as salvage therapy

Adding ganetespib to docetaxel offered no survival benefit in advanced lung adenocarcinoma.